ERK1/2 activation in rat ventral tegmental area by the mu-opioid agonist fentanyl: an in vitro study

Neuroscience. 2003;116(1):139-44. doi: 10.1016/s0306-4522(02)00552-3.

Abstract

Opioid receptors in the ventral tegmental area, predominantly the mu-opioid receptors, have been suggested to modulate reinforcement sensitivity for both opioid and non-opioid drugs of abuse. The present study was conducted to study signal transduction proteins, which may mediate the functioning of mu-opioid receptors in the neurons of the ventral tegmental area. Therefore, brain slices of the ventral tegmental area were exposed in vitro to the specific mu-opioid agonist fentanyl and immunohistochemically stained for four different activated proteins using phospho-specific antibodies. Fentanyl dose-dependently activated extracellular signal-regulated protein in brain slices of the ventral tegmental area. This activation was reversible with naloxone. Furthermore, naloxone itself also activated extracellular signal-regulated protein kinase. Under the present conditions fentanyl did not affect extracellular signal-regulated protein kinase 1 and 2, Stat and cyclic AMP-response element-binding protein activity. The direct activation of extracellular signal-regulated protein kinase in ventral tegmental area slices by the mu-opioid agonist fentanyl may suggest a role of extracellular signal-regulated protein kinase in reward processes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Animals
  • Blotting, Western
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Enzyme Activation / drug effects
  • Fentanyl / pharmacology*
  • Immunohistochemistry
  • MAP Kinase Kinase 1
  • MAP Kinase Kinase 2
  • Male
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Mitogen-Activated Protein Kinases / metabolism*
  • Phosphorylation / drug effects
  • Protein Serine-Threonine Kinases / metabolism
  • Protein-Tyrosine Kinases / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Opioid, mu / metabolism*
  • Signal Transduction* / drug effects
  • Ventral Tegmental Area / enzymology*

Substances

  • Analgesics, Opioid
  • Cyclic AMP Response Element-Binding Protein
  • Receptors, Opioid, mu
  • Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 1
  • MAP Kinase Kinase 2
  • Mitogen-Activated Protein Kinase Kinases
  • Fentanyl